Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumors.
Ghadimi MP, Young ED, Belousov R, Zhang Y, Lopez G, Lusby K, Kivlin C, Demicco EG, Creighton CJ, Lazar AJ, Pollock RE, Lev D.
Ghadimi MP, et al. Among authors: creighton cj.
Clin Cancer Res. 2012 May 1;18(9):2545-57. doi: 10.1158/1078-0432.CCR-11-2592. Epub 2012 Mar 8.
Clin Cancer Res. 2012.
PMID: 22407831
Free PMC article.